000			02020 a2200517 4500
005			20250515011702.0
264		0	_c20060503
008			200605s 0 0 eng d
022			_a0946-1965
024	7		_a10.5414/cpp43592 _2doi
040			_aNLM _beng _cNLM
100	1		_aJakobs, S
245	0	0	_aMolecular targets of indirubins. _h[electronic resource]
260			_bInternational journal of clinical pharmacology and therapeutics _cDec 2005
300			_a592-4 p. _bdigital
500			_aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAntineoplastic Agents _xpharmacology
650	0	4	_aApoptosis
650	0	4	_aCSK Tyrosine-Protein Kinase
650	0	4	_aCell Line, Tumor
650	0	4	_aCyclin-Dependent Kinases _xantagonists & inhibitors
650	0	4	_aCyclins _xantagonists & inhibitors
650	0	4	_aDrug Screening Assays, Antitumor
650	0	4	_aHumans
650	0	4	_aIndoles _xchemistry
650	0	4	_aInhibitor of Apoptosis Proteins
650	0	4	_aMicrotubule-Associated Proteins _xantagonists & inhibitors
650	0	4	_aMonosaccharides _xpharmacology
650	0	4	_aMyeloid Cell Leukemia Sequence 1 Protein
650	0	4	_aNeoplasm Proteins _xantagonists & inhibitors
650	0	4	_aOximes
650	0	4	_aPhosphorylation
650	0	4	_aProtein Kinase Inhibitors _xchemistry
650	0	4	_aProtein-Tyrosine Kinases _xantagonists & inhibitors
650	0	4	_aProto-Oncogene Proteins _xantagonists & inhibitors
650	0	4	_aProto-Oncogene Proteins c-bcl-2 _xantagonists & inhibitors
650	0	4	_aRetinoblastoma Protein _xmetabolism
650	0	4	_aSTAT3 Transcription Factor _xantagonists & inhibitors
650	0	4	_aSurvivin
650	0	4	_asrc-Family Kinases
700	1		_aMerz, K H
700	1		_aVatter, S
700	1		_aEisenbrand, G
773	0		_tInternational journal of clinical pharmacology and therapeutics _gvol. 43 _gno. 12 _gp. 592-4
856	4	0	_uhttps://doi.org/10.5414/cpp43592 _zAvailable from publisher's website
999			_c15991342 _d15991342